Retroviral-mediated transfer and expression of hepatitis B e antigen in human primary skin fibroblasts and Epstein-Barr virus-transformed B lymphocytes.

No abstract is available for this paper.

• Publication year

  1989

• Venue

  Virology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/0042-6822(89)90400-5PMID 2783354
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human purine nucleoside phosphorylase and adenosine deaminase: gene transfer into cultured cells and murine hematopoietic stem cells by using recombinant amphotropic retroviruses

  1987cited by this paper
• Efficient retrovirus-mediated transfer and expression of a human adenosine deaminase gene in diploid skin fibroblasts from an adenosine deaminase-deficient human.

  1987cited by this paper
• Expression of hepatitis B virus surface and core antigens: influences of pre-S and precore sequences

  1987cited by this paper
• Complete correction of the enzymatic defect of type I Gaucher disease fibroblasts by retroviral-mediated gene transfer.

  1987cited by this paper
• Variable stability of a selectable provirus after retroviral vector gene transfer into human cells

  1986cited by this paper
• Human T lymphocyte clones specific for malaria (Plasmodium falciparum) antigens.

  1985cited by this paper
• Relationship Between Expression of Hepatitis B Virus Antigens in Isolated Hepatocytes and Autologous Lymphocyte Cytotoxicity in Patients with Chronic Hepatitis B Virus Infection

  1984cited by this paper
• Viral hepatitis and liver disease

  1984cited by this paper
• Amphotropic retrovirus vector system for human cell gene transfer

  1984cited by this paper
• High-frequency transfection and cytopathology of the hepatitis B virus core antigen gene in human cells.

  1983cited by this paper
• Cytotoxicity by NK-like cells from hepatitis B-immune patients to a human hepatoma cell line secreting HBsAg.

  1983cited by this paper
• Specificity of T lymphocyte cytotoxicity to autologous hepatocytes in chronic hepatitis B virus infection: evidence that T cells are directed against HBV core antigen expressed on hepatocytes.

  1982cited by this paper
• Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

  1982cited by this paper
• Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein.

  1981cited by this paper
• 1 Origins of Contemporary DNA Tumor Virus Research

  1980cited by this paper
• MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness.

  1979cited by this paper
• Antibody-dependent cell-mediated cytotoxicity (ADCC) and cell-mediated cytotoxicity (CMC) to HBsAg-coated target cells in patients with hepatitis B and chronic hepatitis (CAH).

  1979cited by this paper
• Cell-mediated cytotoxicity in chronic active liver disease: A new test system

  1978cited by this paper
• Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases.

  1978cited by this paper
• Cell-mediated cytotoxicity in chronic active liver disease: a new test system.

  1978cited by this paper
• T lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease.

  1978cited by this paper
• T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection

  1977cited by this paper
• Lymphocyte cytotoxicity and inhibition studied with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome.

  1976cited by this paper
• Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis.

  1975cited by this paper
• Cell-mediated immunity in acute and chronic hepatitis.

  1975cited by this paper
• Immunological studies in patients with chronic active hepatitis. Cytotoxic activity of lymphocytes to autochthonous liver cells grown in tissue culture.

  1975cited by this paper
• Cellular immunity and hepatitis-associated, Australia antigen liver disease.

  1972cited by this paper

• The cellular immune response to nucleocapsid antigens in hepatitis B virus infection

  2004cites this paper
• Alpha-1-antitrypsin deficiency: biochemistry and clinical manifestations.

  1996cites this paper
• Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission.

  1994cites this paper
• Assessment of the Efficacy of Purging by Using Gene Marked Autologous Marrow Transplantation for Children with AML in First Complete Remission. St. Jude Children's Research Hospital, Memphis, Tennessee

  1994cites this paper
• Advances in recombinant retroviruses for gene delivery

  1993cites this paper
• Low frequency of cytotoxic liver-infiltrating T lymphocytes specific for endogenous processed surface and core proteins in chronic hepatitis B.

  1993cites this paper
• Proliferative and cytotoxic T‐cell clones recognize endogenously synthesized HBcAG in an asymptomatic HBsAg carrier

  1993cites this paper
• Autologous bone marrow transplant for children with AML in first complete remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

  1991cites this paper
• A Phase I Trial of High-Dose Carboplatin and Etoposide with Autologous Marrow Support for Treatment of Relapse/Refractory Neuroblastoma Without Apparent Bone Marrow Involvement: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse

  1991cites this paper
• A Phase I Trial of High-Dose Carboplatin and Etoposide with Autologous Marrow Support for Treatment of Stage D Neuroblastoma in First Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse

  1991cites this paper
• Autologous Bone Marrow Transplant for Children with AML in First Complete Remission: Use of Marker Genes to Investigate the Biology of Marrow Reconstitution and the Mechanism of Relapse

  1991cites this paper
• Effect of Interleukin-4 on Cytolytic T Cells

  1991cites this paper
• A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of relapse/refractory neuroblastoma without apparent bone marrow involvement: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

  1991cites this paper
• A phase I trial of high-dose carboplatin and etoposide with autologous marrow support for treatment of stage D neuroblastoma in first remission: use of marker genes to investigate the biology of marrow reconstitution and the mechanism of relapse.

  1991cites this paper
• Expression of HBV envelope and nucleocapsid proteins in human cells using vaccinia virus vectors.

  1990cites this paper